Author: Jesse Landry

Poetiq did not come out of stealth quietly. It walked onto the floor in January 2026, Mountain View address on the label, $45.8 million in Seed capital on the table, and a very specific message humming under the noise. The models are not broken. The way we ask them to think is. Founded in June 2025 by Shumeet Baluja, PhD and Ian Fischer, both alumni of Google DeepMind, Poetiq was built on a simple refusal to accept that reasoning should cost weeks of retraining and millions in compute just to get a straight answer. The story starts at DeepMind, where…

In Devens, Massachusetts, VulcanForms did what serious manufacturing companies do when the moment demands it. They raised $220 million in an oversubscribed Series D and did not bother turning it into a victory lap. This was capital with intent. Led by Eclipse and 1789 Capital, with Washington Harbour, Fontinalis Partners, IEQ Capital, and other strategic partners in the room, the round pushed total funding to roughly $725 million and quietly reinforced a larger message. The United States is done pretending critical metal production can live offshore without consequence. VulcanForms was never built as a software deck chasing buzz. Founded in…

Houston has a way of hiding serious science in plain sight. Tucked inside the Levit Green life sciences district, steps from the Texas Medical Center, PranaX Corporation has been quietly building something that does not shout, does not posture, and does not apologize. Founded in November 2022 by Steven J. Greco, PhD, PranaX was designed around a simple premise with a long shadow: if cells already know how to heal, maybe the smartest move is to listen to what they are saying. That conversation happens through exosomes, microscopic messengers measuring 30 to 150 nanometers, carrying instructions that tell tissues how…

Epikast did not come out of a lab fantasy or a pitch deck fever dream. It came out of a very real frustration with how biopharma actually shows up in the world. Founded in 2021 and headquartered in New York with a serious operating backbone in Athens, Epikast looked at commercial, medical affairs, and patient engagement and asked why so much money was being burned to say so little. The answer became the business. Dr. Vangelis Vergetis, PhD, CEO and co-founder, has spent his career bouncing between code, data, and the sharp end of healthcare reality. McKinsey taught him how…

Redwood Materials does not feel like a startup announcement. It feels like a supply chain deciding it is tired of improvising. Founded in 2017 and headquartered in Sparks and Carson City, Nevada, Redwood was built by Jeffrey Straubel after fifteen years as Tesla’s Chief Technology Officer, watching batteries scale faster than the systems meant to recover them. The bet was simple and uncomfortable. If lithium ion batteries were going to define the next century, someone had to own the afterlife. Redwood Materials closed its Series E at $425 million. The round opened in October and pulled in another $75 million…

DexMat does not sound like a materials company until you realize materials quietly decide who wins decades later. Based in Houston, Texas, DexMat was born from Rice University science that refused to stay academic. The work traces back to Nobel laureate Richard Smalley asking a dangerous question in 2000 about wet spinning carbon nanotubes, and to Matteo Pasquali carrying that work forward after 2005 with the patience of someone who knew the clock was on his side. By 2013, aligned nanotube fibers with metal grade conductivity stopped being theory. By 2015, DexMat existed to make it real. The product is…

January 26, 2026 did not arrive with fireworks. It arrived with math. Primmune Therapeutics, out of Carlsbad, California, quietly closed an additional $8.6 million in Series B financing, bringing the round to $23.3 million and total equity raised to $61.7 million. No valuation talk. No victory laps. Just capital moving with purpose toward a Phase 2 moment that has been earned the long way. Primmune Therapeutics was founded October 3, 2017 by James Appleman, Ph.D., Paulo Rangel, and Stephen Webber, Ph.D., a trio fluent in the language of compounds that work and programs that survive. This company came out of…

Terra Energy did not wake up one morning and decide to sell solar. It decided to sell relief. Relief from upfront costs, relief from paperwork purgatory, relief from the quiet panic homeowners feel when the grid flickers and the bill climbs anyway. Founded in February 2016, Terra Energy came out of Mexico with a clear-eyed view of a market full of sunlight and short on access. Luis Roberto Perez-Aguirre saw it first, structuring solar as a subscription instead of a financial obstacle course. Jaime Martinez brought the engineering muscle and the conviction that clean power should feel boring in the…

Breathing is the one thing everyone does and almost nobody thinks about until it is taken from them. Climatic decided that blind spot was not a mystery, it was an opportunity hiding in plain air. New York based, born in May 2023, Climatic stepped out of stealth on January 28, 2026 with a $10 million seed round and a very specific conviction. Lung health should be a daily habit, not a crisis response. The company was founded by Allie Melnick, the builder who helped take Flamingo from zero to more than $50 million in annual revenue and onto shelves at…

Oats Overnight has always felt like a dare. Not to breakfast, but to the idea that mornings have to be slow, messy, or nutritionally bankrupt. Founded in Phoenix in August 2016, Oats Overnight started with Brian Tate, a former high-stakes poker player who spent twelve years reading tables, managing risk, and knowing when patience beats panic. He left the cards in 2017 and brought that same discipline to oats, protein, and a shaker bottle, building the first versions in his own kitchen and clearing $9M in revenue by 2019. Oats Overnight secured a $45M growth equity investment from Astō Consumer…